SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-24-004573
Filing Date
2024-01-30
Accepted
2024-01-30 16:31:21
Documents
1
Group Members
DAVID C. OTTO. ANDREAS HALVORSENROSE S. SHABETVIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LPVIKING GLOBAL OPPORTUNITIES DRAWDOWN GP LLCVIKING GLOBAL OPPORTUNITIES DRAWDOWN PORTFOLIO GP LLCVIKING GLOBAL OPPORTUNITIES GP LLCVIKING GLOBAL OPPORTUNITIES

Document Format Files

Seq Description Document Type Size
1 SC 13G ef20020178_sc13g.htm SC 13G 355054
  Complete submission text file 0001140361-24-004573.txt   357216
Mailing Address 600 WASHINGTON BLVD. FLOOR 11 STAMFORD CT 06901
Business Address 600 WASHINGTON BLVD. FLOOR 11 STAMFORD CT 06901 212-672-7050
VIKING GLOBAL INVESTORS LP (Filed by) CIK: 0001103804 (see all company filings)

IRS No.: 134055118 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Subject) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91490 | Film No.: 24578613
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)